206 related articles for article (PubMed ID: 28881484)
1. Primary cells in BCR/FGFR1-positive 8p11 myeloproliferative syndrome are sensitive to dovitinib, ponatinib, and dasatinib.
Landberg N; Dreimane A; Rissler M; Billström R; Ågerstam H
Eur J Haematol; 2017 Nov; 99(5):442-448. PubMed ID: 28881484
[TBL] [Abstract][Full Text] [Related]
2. Activity of TKI258 against primary cells and cell lines with FGFR1 fusion genes associated with the 8p11 myeloproliferative syndrome.
Chase A; Grand FH; Cross NC
Blood; 2007 Nov; 110(10):3729-34. PubMed ID: 17698633
[TBL] [Abstract][Full Text] [Related]
3. Functional characterization, localization, and inhibitor sensitivity of the TPR-FGFR1 fusion in 8p11 myeloproliferative syndrome.
Malli T; Buxhofer-Ausch V; Rammer M; Erdel M; Kranewitter W; Rumpold H; Marschon R; Deutschbauer S; Simonitsch-Klupp I; Valent P; Muellner-Ammer K; Sebesta C; Birkner T; Webersinke G
Genes Chromosomes Cancer; 2016 Jan; 55(1):60-8. PubMed ID: 26391436
[TBL] [Abstract][Full Text] [Related]
4. Activity of fibroblast growth factor receptor inhibitors TKI258, ponatinib and AZD4547 against TPR‑FGFR1 fusion.
Qiu XH; Li F; Cao HQ; Shao JJ; Mei JG; Li HQ; Zhai YP
Mol Med Rep; 2017 Mar; 15(3):1024-1030. PubMed ID: 28138694
[TBL] [Abstract][Full Text] [Related]
5. Screening of drugs to treat 8p11 myeloproliferative syndrome using patient-derived induced pluripotent stem cells with fusion gene CEP110-FGFR1.
Yamamoto S; Otsu M; Matsuzaka E; Konishi C; Takagi H; Hanada S; Mochizuki S; Nakauchi H; Imai K; Tsuji K; Ebihara Y
PLoS One; 2015; 10(3):e0120841. PubMed ID: 25803811
[TBL] [Abstract][Full Text] [Related]
6. Myeloproliferative neoplasms with t(8;22)(p11.2;q11.2)/BCR-FGFR1: a meta-analysis of 20 cases shows cytogenetic progression with B-lymphoid blast phase.
Montenegro-Garreaud X; Miranda RN; Reynolds A; Tang G; Wang SA; Yabe M; Wang W; Fang L; Bueso-Ramos CE; Lin P; Medeiros LJ; Lu X
Hum Pathol; 2017 Jul; 65():147-156. PubMed ID: 28551329
[TBL] [Abstract][Full Text] [Related]
7. Functional characterization of two rare BCR-FGFR1
Barnes EJ; Leonard J; Medeiros BC; Druker BJ; Tognon CE
Cold Spring Harb Mol Case Stud; 2020 Apr; 6(2):. PubMed ID: 31980503
[TBL] [Abstract][Full Text] [Related]
8. [8p11 myeloproliferative syndrome].
Li F; Zhai YP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Aug; 21(4):1073-7. PubMed ID: 23998615
[TBL] [Abstract][Full Text] [Related]
9. A case of 8p11 myeloproliferative syndrome with BCR-FGFR1 gene fusion presenting with trilineage acute leukemia/lymphoma, successfully treated by cord blood transplantation.
Morishige S; Oku E; Takata Y; Kimura Y; Arakawa F; Seki R; Imamura R; Osaki K; Hashiguchi M; Yakushiji K; Mizuno S; Yoshimoto K; Nagafuji K; Ohshima K; Okamura T
Acta Haematol; 2013; 129(2):83-9. PubMed ID: 23171834
[TBL] [Abstract][Full Text] [Related]
10. [The 8p11 myeloproliferative syndrome: a review of recent literature].
Kirito K
Rinsho Ketsueki; 2019; 60(9):1157-1165. PubMed ID: 31597839
[TBL] [Abstract][Full Text] [Related]
11. Favorable outcome of allogeneic hematopoietic cell transplantation for 8p11 myeloproliferative syndrome associated with BCR-FGFR1 gene fusion.
Dolan M; Cioc A; Cross NC; Neglia JP; Tolar J
Pediatr Blood Cancer; 2012 Jul; 59(1):194-6. PubMed ID: 22106025
[TBL] [Abstract][Full Text] [Related]
12. A case of a patient characterized by t(8;22)(p11;q11) and BCR/FGFR1 fusion gene, who was successfully treated with haploidentical hematopoietic stem cell transplantation.
Chen X; Huang L; Zheng C; Wang Z
Hematology; 2021 Dec; 26(1):691-696. PubMed ID: 34493159
[No Abstract] [Full Text] [Related]
13. Fusion of the BCR and the fibroblast growth factor receptor-1 (FGFR1) genes as a result of t(8;22)(p11;q11) in a myeloproliferative disorder: the first fusion gene involving BCR but not ABL.
Fioretos T; Panagopoulos I; Lassen C; Swedin A; Billström R; Isaksson M; Strömbeck B; Olofsson T; Mitelman F; Johansson B
Genes Chromosomes Cancer; 2001 Dec; 32(4):302-10. PubMed ID: 11746971
[TBL] [Abstract][Full Text] [Related]
14. Modeling the human 8p11-myeloproliferative syndrome in immunodeficient mice.
Agerstam H; Järås M; Andersson A; Johnels P; Hansen N; Lassen C; Rissler M; Gisselsson D; Olofsson T; Richter J; Fan X; Ehinger M; Fioretos T
Blood; 2010 Sep; 116(12):2103-11. PubMed ID: 20554971
[TBL] [Abstract][Full Text] [Related]
15. B-cell acute lymphoblastic leukemia as evolution of a 8p11 myeloproliferative syndrome with t(8;22)(p11;q11) and BCR-FGFR1 fusion gene.
Baldazzi C; Iacobucci I; Luatti S; Ottaviani E; Marzocchi G; Paolini S; Stacchini M; Papayannidis C; Gamberini C; Martinelli G; Baccarani M; Testoni N
Leuk Res; 2010 Oct; 34(10):e282-5. PubMed ID: 20594995
[No Abstract] [Full Text] [Related]
16. Allogeneic hematopoietic stem cell transplantation for 8p11 myeloproliferative syndrome with BCR-FGFR1 gene rearrangement: a case report and literature review.
Konishi Y; Kondo T; Nakao K; Asagoe K; Otsuka Y; Nishikori M; Hishizawa M; Yamashita K; Takaori-Kondo A
Bone Marrow Transplant; 2019 Feb; 54(2):326-329. PubMed ID: 30087462
[No Abstract] [Full Text] [Related]
17. 8p11 Myeloproliferative syndrome with BCR-FGFR1 rearrangement presenting with T-lymphoblastic lymphoma and bone marrow stromal cell proliferation: a case report and review of the literature.
Kim SY; Oh B; She CJ; Kim HK; Jeon YK; Shin MG; Yoon SS; Lee DS
Leuk Res; 2011 May; 35(5):e30-4. PubMed ID: 21239058
[No Abstract] [Full Text] [Related]
18. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations.
Roumiantsev S; Krause DS; Neumann CA; Dimitri CA; Asiedu F; Cross NC; Van Etten RA
Cancer Cell; 2004 Mar; 5(3):287-98. PubMed ID: 15050920
[TBL] [Abstract][Full Text] [Related]
19. Response to Tyrosine Kinase Inhibitors in Myeloproliferative Neoplasia with 8p11 Translocation and
Wehrli M; Oppliger Leibundgut E; Gattiker HH; Manz MG; Müller AM; Goede JS
Oncologist; 2017 Apr; 22(4):480-483. PubMed ID: 28242791
[TBL] [Abstract][Full Text] [Related]
20. The 8p11 myeloproliferative syndrome: a distinct clinical entity caused by constitutive activation of FGFR1.
Macdonald D; Reiter A; Cross NC
Acta Haematol; 2002; 107(2):101-7. PubMed ID: 11919391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
